Joseph P. Hagan - May 18, 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Joseph P. Hagan
Stock symbol
AUPH
Transactions as of
May 18, 2023
Transactions value $
-$2,878
Form type
4
Date filed
5/23/2023, 05:18 PM
Previous filing
Jan 17, 2023
Next filing
Aug 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Options Exercise +8.73K +249.51% 12.2K May 18, 2023 Direct F1
transaction AUPH Common Stock Sale -$2.88K -272 -2.22% $10.58 12K May 19, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Restricted Stock Units Options Exercise $0 -8.73K -100% $0.00* 0 May 18, 2023 Common Stock 8.73K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
F2 Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.